Imunofan rectal suppositories 5 pcs
Condition: New product
990 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Arginyl-alpha-aspartyl-lysyl-valyl-tyrosyl-arginine
Release form
Suppositories
Composition
Active ingredient: Imunofan Concentration of active ingredient (mg): 0.1
Pharmacological effect
The drug has an immunoregulatory, detoxification, hepatoprotective effect and causes inactivation of free radical and peroxide compounds. Pharmacological action is based on the achievement of three main effects: correction of the immune system, restoring the balance of the oxidative-antioxidant reaction of the body and inhibition of multidrug resistance mediated by proteins of the transmembrane cell transport pump.
Indications
Used in adults and children older than two years for the prevention and treatment of immunodeficiency and toxic conditions, chronic inflammatory diseases of various etiologies. In adults, as an adjuvant during vaccination against bacterial and viral infections.
Contraindications
Hypersensitivity; Pregnancy, complicated rhesus-conflict; Children's age up to 2 years.
Use during pregnancy and lactation
Due to insufficient knowledge in pregnancy and during breastfeeding, they are used only if the intended benefit to the mother outweighs the potential risk to the fetus and child.
Dosage and administration
Rectally. Single dose and daily - 100 mcg (0.1 mg) 1 suppository. When treating cancer patients in the scheme of radical combined treatment (chemo-radiation therapy and surgery) Once a day, the course of treatment 8 to 10 suppositories before chemo-radiation therapy and surgery with the subsequent continuation of the course during the entire period of treatment. In patients with a common tumor process (stage III - IV) of various localization in the form of complex or symptomatic therapy. Once a day, the course of treatment is 8 to 10 suppositories, with an interval of 15-20 days ovtoreniem courses throughout the period subsequent lecheniya.U children with malignant diseases of the hematopoietic and lymphoid tkani1 times a day, every day, a course of treatment 10-20 suppositories. The purpose of the drug should be carried out during the entire course of chemo-radiation therapy and after the end of the course to prevent the development of toxicosis. In complex therapy of children withpapilomatosis of the larynx and oropharynx 1 times a day, every day, a course of treatment of 10 suppositories. In opportunistic infections (cytomegalovirus and herpes infection, toxoplasmosis, chlamydia, pneumocystis, cryptosporidiosis) once a day, daily treatment 15 - 20 suppositories. -infection1 once a day, every day, a course of treatment 15 to 20 suppositories. If necessary, repeat courses should be held in 2-4 weeks. In chronic viral hepatitis and chronic brucellosis 1 times a day, every day, a course of treatment of 15 to 20 suppositories, to prevent recurrence, repeat courses should be carried out in 2 to 3 months. In diphtheria 1 times a day , daily, a course of treatment 8 to 10 suppositories. In diphtheria bacterial carrier - 1 time in 3 days - 3-5 suppositories. In the treatment of III-IV degree burns with symptoms of toxemia, septicotoxemia, in surgical patients with septic endocarditis, long-term non-healing wounds of the extremities, purulent-septic complications 1 time a day, every day, treatment 7 - 10 suppositories, if necessary, the course of the drug should be continued up to 20 suppositories. In case of broncho-obstructive syndrome, cholecystopancreatitis, rheumatoid arthritis 1 time in 3 days, the treatment course is 8 - 10 suppositories, in case If necessary, the course should be continued up to 20 suppositories at the same interval. When treating psoriasis, once a day, every day, a course of treatment is 15 to 20 suppositories. In adults, in the vaccination plan, once a day, the vaccination.
Side effects
Possible: idiosyncrasy, allergic reactions.
Overdose
Cases of overdose are not known.
Interaction with other drugs
In clinical practice, no cases of interaction of Imunofan with other drugs have been reported.
special instructions
As a result of the activation of phagocytosis, a short-term exacerbation of the foci of chronic inflammation, supported by the persistence of viral or bacterial antigens, is possible.